Novartis Unveils Zero Profit COVID-19 Drugs Portfolio
Dexamethasone On List For Low-Income Countries
Lutz Hegemann, chief operating officer for global health at Novartis, tells Scrip the project will continue until a vaccine or curative treatments have reached the world's poorest places, not just until they are first approved in a high income country.
